Cargando…
TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate
BACKGROUND: Inflammation is implicated in causing diabetes. We tested whether transcription factor 7 like-2 (TCF7L2) gene polymorphisms (rs12255372 and rs7903146), consistently associated with type 2 diabetes, are associated with plasma concentrations of inflammatory markers before and after three w...
Autores principales: | Kabagambe, Edmond K, Glasser, Stephen P, Ordovas, Jose M, Warodomwichit, Daruneewan, Tsai, Michael Y, Hopkins, Paul N, Borecki, Ingrid B, Wojczynski, Mary, Arnett, Donna K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766367/ https://www.ncbi.nlm.nih.gov/pubmed/19825152 http://dx.doi.org/10.1186/1758-5996-1-16 |
Ejemplares similares
-
Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS
por: Wood, Alexis C, et al.
Publicado: (2011) -
Genetic Risk Scores Associated with Baseline Lipoprotein Subfraction Concentrations Do Not Associate with Their Responses to Fenofibrate
por: Frazier-Wood, Alexis C., et al.
Publicado: (2014) -
High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering drugs and diet network (GOLDN): an interventional study
por: Wojczynski, Mary K, et al.
Publicado: (2011) -
A clustering analysis of lipoprotein diameters in the metabolic syndrome
por: Frazier-Wood, Alexis C, et al.
Publicado: (2011) -
Short-term effect of fenofibrate on C-reactive protein: A meta-analysis of randomized controlled trials
por: Ye, Jiatao, et al.
Publicado: (2011)